Alsius Corporation (NASDAQ:ALUS), Irvine, Calif., the worldwide
leader in intravascular patient temperature management therapies, has
received approval from regulatory authorities in China and Mexico to
market its intravascular temperature management (IVTM(TM)) systems and
catheters in those countries. Alsius IVTM(TM) provides cooling and
warming therapy via a computer-controlled temperature regulation system
that connects to Alsius' proprietary heat exchange catheters.
"Although we are still at the very early stages of development
in Asia and Latin America, we are excited about introducing the first
intravascular temperature management product in China and Mexico and
hope to leverage this advantage to grow those markets," said Bill
Worthen, president and CEO of Alsius. "Alsius continues to make
progress in growing the international market for its
'inside-out' approach to therapeutic temperature
management."
Last year, Alsius hired a sales manager to oversee growth of the
Asia-Pacific region. The company currently has regulatory approval in
Thailand, South Korea, Australia, Taiwan and Malaysia. Additionally,
there is an application in process in Japan, and the company has
initiated the regulatory approval process in several other countries.
Alsius IVTM(TM)
Alsius' IVTM(TM) consists of the CoolGard 3000, Thermogard and
Thermogard XP systems and a family of single-use catheters, including
the Icy, Fortius and Quattro catheters. The catheters are inserted into
a major vein through a patient's neck or groin, and circulate cool
or warm saline in a closed-loop through balloons that surround the
catheters. This approach decreases or increases core temperature from
the inside of the body out toward the exterior, allowing for
significantly more rapid control of a patient's core body
temperature, with greater efficiency and precision, compared to
conventional external temperature management products such as cooling
and warming blankets and ice packs.
About Alsius
Alsius, headquartered in Irvine, CA, is a medical device company
that develops, manufactures and sells proprietary products to precisely
control patient temperature in hospital critical care settings.
Controlling body temperature, through cooling and warming, is becoming
the standard of care for patients in select critical conditions and
those undergoing a variety of surgical procedures. Alsius markets a
comprehensive suite of catheter-based intravascular temperature
management products that address the need for effective, accurate,
easy-to-use and cost-effective control of body temperature in critical
care patients.
For more information, visit http://www.alsius.com or call
949/453-0150.
COPYRIGHT 2008 Worldwide
Videotex Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.